|
|
Christopher Jones, Rita Garuti, Peter Michaely, Wei-Ping Li, Nobuyo Maeda, Jonathan C. Cohen, Joachim Herz, Helen H. Hobbs
J Clin Invest. 2007;
117(1):165
doi:10.1172/JCI29415
Abstract |
Full text
| PDF
| Supplemental material

G
enetic defects in LDL clearance result in severe hypercholesterolemia and premature atherosclerosis. Mutations in the LDL receptor (LDLR) cause familial hypercholesterolemia (FH), the most severe form of genetic hypercholesterolemia. A phenocopy of FH, autosomal recessive hypercholesterolemia (ARH), is due to mutations in an adaptor protein involved in LDLR internalization. Despite comparable reductions in LDL clearance rates, plasma LDL levels are substantially lower in ARH than in FH. To determine the metabolic basis for this difference, we examined the synthesis and catabolism of VLDL in murine models of FH (Ldlr–/–) and ARH (Arh–/–). The hyperlipidemic response to a high-sucrose diet was greatly attenuated in Arh–/– mice compared with Ldlr–/– mice despite similar rates of VLDL secretion. The rate of VLDL clearance was significantly higher in Arh–/– mice than in Ldlr–/– mice, suggesting that LDLR-dependent uptake of VLDL is maintained in the absence of ARH. Consistent with these findings, hepatocytes from Arh–/– mice (but not Ldlr–/– mice) internalized β-migrating VLDL (β-VLDL). These results demonstrate that ARH is not required for LDLR-dependent uptake of VLDL by the liver. The preservation of VLDL remnant clearance attenuates the phenotype of ARH and likely contributes to greater responsiveness to statins in ARH compared with FH.
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal.
Not all publishers participate in CrossRef, so this information is not comprehensive.
Additionally, data may not reflect the most current citations to this article,
and the data may differ from citation information available from other sources
(for example, Google Scholar, Web of Science, and Scopus).
Total citations by year
in CrossRef
Citations to this article
in CrossRef
(7)
| Title and authors |
Publication |
Year |
The metabolism of triglyceride-rich lipoproteins revisited: New players, new insight
Geesje M. Dallinga-Thie, Remco Franssen, Hans L. Mooij, Maartje E. Visser, H. Carlijne Hassing, Frank Peelman, John J.P. Kastelein, Miklós Péterfy, Max Nieuwdorp
|
Atherosclerosis
|
2010 |
Molecular pathways and agents for lowering LDL-cholesterol in addition to statins
Philippe Costet
|
Pharmacology & Therapeutics
|
2010 |
The ARH adaptor protein regulates endocytosis of the ROMK potassium secretory channel in mouse kidney
Liang Fang, Rita Garuti, Bo-Young Kim, James B. Wade, Paul A. Welling
|
J. Clin. Invest.
|
2009 |
Molecular processes that handle — and mishandle — dietary lipids
Kevin Jon Williams
|
J. Clin. Invest.
|
2008 |
Niemann-Pick C1 protects against atherosclerosis in mice via regulation of macrophage intracellular cholesterol trafficking
Jessie R. Zhang, Trey Coleman, S. Joshua Langmade, David E. Scherrer, Lindsay Lane, M. Hunter Lanier, Chu Feng, Mark S. Sands, Jean E. Schaffer, Clay F. Semenkovich, Daniel S. Ory
|
J. Clin. Invest.
|
2008 |
Identification of a VLDL-induced, FDNPVY-independent internalization mechanism for the LDLR
Peter Michaely, Zhenze Zhao, Wei-Ping Li, Rita Garuti, Lily J Huang, Helen H Hobbs, Jonathan C Cohen
|
EMBO J
|
2007 |
Atherogenic remnant lipoproteins: role for proteoglycans in trapping, transferring, and internalizing
Robert W. Mahley, Yadong Huang
|
J. Clin. Invest.
|
2007 |
|